Understanding how BH3-only proteins initiate apoptosis in response to chemotherapy [ 2015 - 2017 ]

Research Grant

Researchers: A/Pr Grant Dewson (Principal investigator) ,  Dr Andrew Webb

Brief description Failure to initiate cell death is a hallmark in the development of the majority of cancers and killing all tumour cells is essential for effective cancer treatment. A group of proteins termed the BH3-only proteins normally sense cell stress to trigger cell death. Their dysregulation contributes to cancer and failure to respond to chemotherapy. Understanding how these proteins function to induce cell death will allow the design of drugs that mimic this activity for improved cancer therapy.

Funding Amount $AUD 481,124.01

Funding Scheme Project Grants

Notes Standard Project Grant